MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*”Architects”: Geriatrics, Gerontology, Geroscience, Longevity, Healthspan & Aging
HexemBio
Organization & Developments: HexemBio
Parents
HexemBio
Children
* It temporarily places a patient's own cells into a recreated version of the embryonic environment where blood stem cells first emerge, then returns them by standard IV infusion.
*Cell restoration technology to enable longevity.
*Focuses on blood stem cells, arguing that deterioration in the body's blood and immune systems may be one of the central drivers of aging.
*HexemBio has built the first lab-grown human yolk sac, the earliest developmental environment that nurtures blood-forming stem cells
*HexemBio is developing what it calls the first blood stem cell rejuvenation therapy.
*Regenerative medicine with scalable and reproducible stem cell therapies to allow restoration of healthy hematopoietic stem cell function and reverse aging.
*The company says this avoids gene editing and chemical reprogramming, which can carry stability or safety risks.
*This youngest biological niche secretes factors that rejuvenate aged stem cells and restore their surrounding tissue environment, offering a new approach to regenerative medicine.
2026: The New Billionaire Bet Isn't AI — It's Longevity Biotech _ www.forbes.com
Synthetic Human Yolk Sac
Jumps
Finance & Acquisitions: HexemBio
Key People: HexemBio